CN Patent

CN105030685B — 一种恩杂鲁胺固体分散体口服制剂

Assigned to FERGUSON (WUHAN) BIOTECHNOLOGY Co Ltd · Expires 2018-02-27 · 8y expired

What this patent protects

本发明公开了一种恩杂鲁胺固体分散体的口服制剂，含有有效剂量的恩杂鲁胺，还含有用于分散恩杂鲁胺的水溶性聚合物载体，所述恩杂鲁胺与水溶性聚合物载体的质量比为1∶0.5～3。本发明有效地提高了制剂中恩杂鲁胺的溶解度和溶出度，从而提高了恩杂鲁胺的生物利用度，同时还提高了恩杂鲁胺的质量稳定性和安全性。

USPTO Abstract

本发明公开了一种恩杂鲁胺固体分散体的口服制剂，含有有效剂量的恩杂鲁胺，还含有用于分散恩杂鲁胺的水溶性聚合物载体，所述恩杂鲁胺与水溶性聚合物载体的质量比为1∶0.5～3。本发明有效地提高了制剂中恩杂鲁胺的溶解度和溶出度，从而提高了恩杂鲁胺的生物利用度，同时还提高了恩杂鲁胺的质量稳定性和安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN105030685B
Jurisdiction
CN
Classification
—
Expires
2018-02-27
Drug substance claim
No
Drug product claim
No
Assignee
FERGUSON (WUHAN) BIOTECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.